Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.
Press releases published on April 1, 2025
Atticus Publishing proudly presents 'You Deserve Life' by Dr. Karen Wright-Chisolm
EIN Presswire
·
April 1, 2025
Unveils Triumph Over Domestic Violence Through Faith CHARLESTON, SC, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- In her profound book, You Deserve Life, Dr. Karen Wright-Chisolm shares her personal journey and stories of those who faced domestic …
VRIZE Recognized Among the Fastest-Growing Companies in the Inc. Southeast Regionals
EIN Presswire
·
April 1, 2025
VRIZE Secures a Spot in the Southeast’s Top 192, Contributing to 11,493 Jobs and an $8.1B Economic Impact TAMPA, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Inc. magazine today announced that VRIZE has been ranked No. 43 on its fifth annual …
Brigitte Poublon Gives Update on former Teen Idol, Bobby Sherman: Bobby is Terminal Ill, Resting Comfortably
EIN Presswire
·
April 1, 2025
On Tuesday, Bobby Sherman’s wife, Brigitte Poublon gave an update on Bobby Sherman’s health: “Bobby Sherman is terminally ill and resting comfortably.” LOS ANGELES, CA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- On Tuesday, Bobby Sherman’s wife, …
C Mauritius Palmar Recertified for Ongoing Commitment to Cultivating Sustainability
EIN Presswire
·
April 1, 2025
Green Globe has recertified C Mauritius Palmar, a premier resort nestled along the coastline of Palmar, for its ongoing excellence in sustainability. SANTA MONICA, CA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Green Globe has officially …
TCIS Africa 2025: Revolutionizing Clinical Research in Africa
EIN Presswire
·
April 1, 2025
TCIS Africa is proud to announce the 6th Annual Clinical Investigators' Summit (TCIS Africa 2025), taking place on May 5-9, 2025, in Dakar, Senegal. DAKAR, SENEGAL, April 1, 2025 /EINPresswire.com/ -- TCIS Africa is proud to announce the 6th Annual …
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
GlobeNewswire
·
April 1, 2025
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …
Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025
GlobeNewswire
·
April 1, 2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2025 operating and financial results on Monday, May 5, 2025, after market close. The Company will host a …
Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET
GlobeNewswire
·
April 1, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on …
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster …
Stallion Uranium Announces C$1.2 Million Private Placement
GlobeNewswire
·
April 1, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to …
GRI Bio Announces Pricing of $5.0 Million Public Offering
GlobeNewswire
·
April 1, 2025
LA JOLLA, CA, April 01, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …
Endeavour Silver Increases Previously Announced Bought Deal Financing to US$45 Million
GlobeNewswire
·
April 1, 2025
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless otherwise noted. VANCOUVER, British Columbia, April 01, …
GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire
·
April 1, 2025
The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed Interim results demonstrate GRI-0621 to be safe and well-tolerated in the first 12 patients evaluated …
Clene to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 1, 2025
SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
GlobeNewswire
·
April 1, 2025
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- Clearmind …
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
GlobeNewswire
·
April 1, 2025
CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …
BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees
GlobeNewswire
·
April 1, 2025
MAHE, Seychelles, April 01, 2025 (GLOBE NEWSWIRE) -- BitMEX, the OG crypto derivatives exchange, today announced significant enhancements to its BMEX Token ecosystem, introducing higher staking rewards, reduced trading fees, and expanded token utility. …
Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis
GlobeNewswire
·
April 1, 2025
Topline data from the single- and multiple-ascending dose studies confirmed safety and favorable tolerability profile of AP02 at all dose levels Full safety, tolerability, and pharmacokinetics data to be presented at the American Thoracic Society 2025 …
Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme
GlobeNewswire
·
April 1, 2025
CARLSBAD, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of Understanding (MOU) to acquire Marizyme (OTC: MRZM). Qualigen and Marizyme have …
Context Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 1, 2025
PHILADELPHIA, April 01, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its …